Entrada Therapeutics Inc.

Entrada Therapeutics Inc. annual/quarterly operating income history and growth rate from 2023 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Entrada Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -42.3 M, a 94.14% increase year-over-year.
• Entrada Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -158.0 M, a 336.20% decrease year-over-year.
• Entrada Therapeutics Inc. annual operating income for 2025 was -157.9 M, a 435.87% decrease from 2024.
• Entrada Therapeutics Inc. annual operating income for 2024 was 47.0 M, a 1586.75% decrease from 2023.
• Entrada Therapeutics Inc. annual operating income for 2023 was -3.2 M.